USPTO serial 85619715
LEO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 30, 2013
- Examiner
- REGAN, JOHN B
- Law office
- TMO LAW OFFICE 113
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with LEO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Simor Moskowitz
Simor Moskowitz Westerman, Hattori, LLP8500 Leesburg PikeSuite 7500Tysons, VA 22182Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ Non-medicated skin and hair care preparations; cosmetic preparations, namely, preparations for the reconditioning of hair and skin after medicinal treatments; medicated soaps; artificial fingernails ] | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of [ cancer and ] dermatological [, hematological, renal and endocrine ] disorders; powders, talcum powders, creams, lotions, gels, foundation and lip balm for the treatment of dermatological disorders [, cancer and skin infections; artificial fingernails for medical use; medical surgical glues and glues for medical use; medical and wound dressings; dressings for the treatment of dermatological disorders, cancer and skin infections; medicated shampoos ] | ACTIVE | — |
| 009 | [ Games software, namely, software for games which provide information relating to cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof; computer application software for calculating use of medicine and containing information on the use of pharmaceutical products; hand-held device for calculating use of medicine and containing information on the use of pharmaceutical products; downloadable electronic publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; sensor chips and bio-chips for research and medical use; downloadable software in the nature of mobile applications in the field of cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof; computer games providing information in relation to cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof; online downloadable software applications containing information on the use of pharmaceutical products and for calculating use of medicine ] | SECTION 8 - CANCELLED | — |
| 010 | Medical apparatus and instruments, namely, medical devices for applying pharmaceutical preparations and for introducing pharmaceutical preparations into the human body; medical devices for the treatment of [ cancer and ] dermatological [, hematological, renal and endocrine ] disorders; medical apparatus and units for dosage, [ measuring and monitoring, ], namely, drug delivery devices [ and systems; medical devices, namely, devices for measuring body surface area affected by disease; medical products, namely, biofeedback sensors; microneedles for medical use ] | ACTIVE | — |
| 016 | [ Publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders ] | SECTION 8 - CANCELLED | — |
| 028 | [ Games, namely, board games and card games providing information in relation to cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof ] | SECTION 8 - CANCELLED | — |
| 035 | [ Providing advertising, marketing and promotional services for pharmaceutical and medical products of others; ] organization of exhibitions and events for commercial or advertising purposes; administration of customer loyalty programs for enabling participants to obtain discounts on pharmaceuticals [ ; wholesale and retail store services and on-line wholesale and retail store services featuring pharmaceutical products and medical devices ] | ACTIVE | — |
| 038 | Providing online forums for the transmission of messages, comments and multimedia content for medical and healthcare professionals, authorities, organizations, patients and families of patients; providing on-line chat rooms and electronic bulletin boards for transmission of messages among medical and healthcare professionals, authorities, organizations, patients and families of patients | ACTIVE | — |
| 040 | [ Custom manufacture of pharmaceuticals ] | SECTION 8 - CANCELLED | — |
| 041 | [ Providing educational and training services, namely, conducting classes, seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; educational training services in the field of treatment of cancer and dermatological, hematological, renal and endocrine disorders; education services, namely, providing on-line classes, seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; arranging and conducting of lectures in the field of cancer and dermatological, hematological, renal and endocrine disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line electronic publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; publication of books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing online educational and informational games in the field of cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof ] | SECTION 8 - CANCELLED | — |
| 042 | Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of [ cancer and ] dermatological [, hematological, renal and endocrine ] disorders; conducting clinical trials for pharmaceutical products in the field of [ cancer and ] dermatological [, hematological, renal and endocrine ] disorders; providing information about the results of clinical trials for pharmaceutical products; providing online non-downloadable software applications containing information on the use of pharmaceutical products and for calculating use of medicine | ACTIVE | — |
| 044 | Providing medical information, consultancy and advisory services; medical and pharmaceutical consultation; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical counseling; medical services, namely, medical care in the field of [ cancer and ] dermatological [, hematological, renal and endocrine ] disorders; planning of medical treatment programs for the treatment of [ cancer and ] dermatological [, hematological, renal and endocrine ] disorders; providing information and advice in the fields of [ cancer and ] dermatological [, hematological, renal and endocrine ] disorders; providing a web site featuring medical information; [ hygienic and beauty care; ] information services in the field of treatment of [ cancer and ] dermatological [, haematological, renal and endocrine ] disorders | ACTIVE | — |
| 045 | [ Personal and social services rendered by others to meet the needs of individuals, namely, providing non-therapeutic counseling and emotional support to patients and families of patients, and providing information to relatives on how to provide emotional support to patients and families of patients ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Leo Pharma A/S
- Other trademarks owned by Leo Pharma A/S
- Other trademarks owned by Leo Pharma A/S
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 028
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named LEO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2023 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Sep 13, 2023 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Sep 13, 2023 | 9G8P | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 | — |
| Sep 13, 2023 | 8PRT | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED | — |
| Sep 13, 2023 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Apr 30, 2022 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jan 10, 2019 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 10, 2019 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 9, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 11, 2018 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 30, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 10, 2017 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Feb 10, 2017 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Feb 10, 2017 | CAND | CANCELLATION DENIED NO. 999999 | — |
| May 12, 2016 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Sep 5, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 30, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 12, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 12, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 23, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 4, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 2, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 21, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 21, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 21, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 5, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 5, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 1, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 1, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 1, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 1, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 27, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 27, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 13, 2012 | ALIE | ASSIGNED TO LIE | — |
| Nov 5, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2012 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 5, 2012 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 5, 2012 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 29, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2012 | MDSM | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| May 15, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2012 | NWAP | NEW APPLICATION ENTERED | — |